Sponsored By

Corporate Finance: Sales and Earnings Continued Up—But at a Slowed Pace

Originally Published MDDI December 2005   2005 MEDTECH SNAPSHOT

December 1, 2005

1 Min Read
Corporate Finance: Sales and Earnings Continued Up—But at a Slowed Pace

Originally Published MDDI December 2005

 

2005 MEDTECH SNAPSHOT

Net income slowed for several device companies, including Boston Scientific, in 2005, according to Merrill Lynch. The charts on these pages provide a look at the financial health of the device industry. Indicators include a chart comparing industry performance with Standard & Poor's 500 and the top 40 public medical manufacturers worldwide, ranked by revenue.

mddi0512p33.jpg

The top 40 public medical manufacturers worldwide, ranked by trailing 12 months (TTM) revenues. Source: Bloomberg.


mddi0512p32a.jpg

Spending by public agencies, like the Centers for Medicare and Medicaid Services (CMS) and Veterans Health Administration, accounted for nearly $442 billion of the annual healthcare spending in 2003. Source: CMS, Office of the Actuary, National Health Statistics Group.

mddi0512p32b.jpg

Office of Regulatory Affairs (ORA) costs for the process of the review of device applications. The costs include total process costs, including costs paid from appropriations and fee revenues. Source: FDA Unit Costs for the Process of Medical Device Review.

Copyright ©2005 Medical Device & Diagnostic Industry

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like